Peter MacCallum Cancer Centre shared a post on LinkedIn:
“Researchers at Peter Mac’s Centre of Health Services Research in Cancer and The National Centre for Infections in Cancer have developed a digital tool that can rapidly and accurately identify patients who develop immune-related colitis – a potentially serious side effect of immunotherapy.
Until now, identifying cases relied on slow, manual case-note review. The new clinician-verified “digital phenotype” uses existing electronic medical record data to automatically flag patients with high accuracy, unlocking faster insights and large-scale research that wasn’t previously possible.
Lead researcher Dr Jasmine Teng Teng says the tool not only improves understanding of how often immune-related colitis occurs, but could also help pave the way for predicting who is at risk – enabling earlier intervention and more personalised cancer treatment.
Published in JCO Clinical Cancer Informatics, this is the first validated tool of its kind for cancer patients in Australia.
Other articles from Peter MacCallum Cancer Centre.